Proshares Trust (ZBIO) Leases (2023 - 2025)
Historic Leases for Zenas BioPharma (ZBIO) over the last 3 years, with Q3 2025 value amounting to $807000.0.
- Zenas BioPharma's Leases rose 10225.56% to $807000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $807000.0, marking a year-over-year increase of 10225.56%. This contributed to the annual value of $1.0 million for FY2024, which is 2228.99% up from last year.
- Per Zenas BioPharma's latest filing, its Leases stood at $807000.0 for Q3 2025, which was up 10225.56% from $1.0 million recorded in Q2 2025.
- Zenas BioPharma's 5-year Leases high stood at $1.2 million for Q1 2025, and its period low was $399000.0 during Q3 2024.
- Its 3-year average for Leases is $874166.7, with a median of $912500.0 in 2023.
- Per our database at Business Quant, Zenas BioPharma's Leases soared by 2228.99% in 2024 and then skyrocketed by 10225.56% in 2025.
- Zenas BioPharma's Leases (Quarter) stood at $821000.0 in 2023, then grew by 22.29% to $1.0 million in 2024, then decreased by 19.62% to $807000.0 in 2025.
- Its Leases was $807000.0 in Q3 2025, compared to $1.0 million in Q2 2025 and $1.2 million in Q1 2025.